Skip to main content
Clinical Trials/CTRI/2020/02/023459
CTRI/2020/02/023459
Not yet recruiting
Phase 2

To study impact of an empirical protocolized management in patients with Non-specific terminal ileal abnormalities (namely ulcer and nodularity)-A pilot study

OT APPLICABLE0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
OT APPLICABLE
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Informed consent
  • Patients who showed terminal ileal ulcers (single or multiple) or nodularity as sole endoscopic abnormality

Exclusion Criteria

  • History of NSAIDs consumption ( \<4 weeks)
  • History of colorectal surgery
  • History of tuberculosis
  • Oral or genital ulcerations
  • Recent history of intake of Angiotensin receptor blockers.
  • Coincidental ulceration in ileo\-cecal valve or colon
  • Known case of inflammatory bowel disease
  • Recent history of gastroenteritis
  • Previous ileal resection.

Outcomes

Primary Outcomes

Not specified

Similar Trials